Education
About Us
Working with TipRanks
Follow Us
CWS - ETF AI Analysis
Top Page
AdvisorShares Focused Equity ETF (CWS)
Rating:72Outperform
Price Target:
$75.00
Positive Factors
Strong Top Holdings
Several of the largest positions, such as IES Holdings and Amphenol, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF is spread across six sectors, including Technology, Industrials, and Health Care, reducing reliance on any single industry.
Consistent Asset Growth
The fund has maintained a healthy level of assets under management, indicating steady investor interest.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.
Geographic Over-Concentration
With nearly all of its exposure in U.S. companies, the fund lacks diversification across global markets.
Mixed Recent Performance
While the year-to-date performance is positive, the ETF has struggled over the past three months, showing slight declines.
CWS vs. SPDR S&P 500 ETF (SPY)
AUM180.36M
RegionNorth America
Expense Ratio0.65%
Beta0.70
IssuerAdvisorShares
Inception DateSep 20, 2016
Dividend Yield0.56%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,411
30 Day Avg. Volume10,295
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.44Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering26
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CWS Summary
The AdvisorShares Focused Equity ETF (CWS) is a fund that invests in a diverse range of companies across the total market, including large, medium, and small businesses. It focuses on industries like technology, healthcare, and industrials, with well-known companies such as Abbott Laboratories and Stryker among its top holdings. This ETF is designed for investors seeking growth and diversification, as it balances stability with the potential for strong performance through strategic stock selection. However, new investors should be aware that the fund’s performance can fluctuate with the overall market, and its focus on specific sectors like technology may increase risk during downturns in those industries.
How much will it cost me?The AdvisorShares Focused Equity ETF (CWS) has an expense ratio of 0.72%, which means you’ll pay $7.20 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning professional managers select stocks rather than tracking an index. Active management often comes with higher costs due to research and decision-making efforts.
What would affect this ETF?The AdvisorShares Focused Equity ETF (CWS), with strong exposure to technology, industrials, and healthcare sectors, could benefit from innovation-driven growth, infrastructure spending, and advancements in medical technology. However, it may face challenges from rising interest rates, which can impact growth stocks, and economic slowdowns that could affect consumer cyclical and industrial sectors. Its U.S.-focused portfolio is also sensitive to domestic regulatory changes and broader economic conditions.
CWS Top 10 Holdings
The AdvisorShares Focused Equity ETF (CWS) leans heavily into technology and industrials, with these sectors making up over half of its portfolio. IES Holdings and Amphenol are rising stars, driving performance with strong financials and bullish trends. Meanwhile, HEICO has been a mixed bag, showing growth potential but facing bearish technical signals. Abbott Laboratories has been lagging recently, weighed down by short-term weakness despite its promising medical device growth. With its U.S.-centric focus and balanced mix of growth and value stocks, CWS offers a strategic play for investors seeking resilience and long-term growth.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amphenol | 7.78% | $14.11M | $170.25B | 95.95% | 77 Outperform | |
| IES Holdings | 7.29% | $13.22M | $7.92B | 37.58% | 75 Outperform | |
| Cencora | 6.17% | $11.18M | $69.93B | 46.39% | 76 Outperform | |
| HEICO | 5.26% | $9.53M | $38.95B | 25.49% | 74 Outperform | |
| Mueller Industries | 5.16% | $9.35M | $11.89B | 12.98% | 78 Outperform | |
| Rollins | 4.81% | $8.73M | $28.40B | 15.09% | 79 Outperform | |
| Abbott Laboratories | 4.22% | $7.65M | $219.72B | 7.78% | 77 Outperform | |
| Thermo Fisher | 4.19% | $7.59M | $215.06B | 5.38% | 73 Outperform | |
| Henry Schein | 3.98% | $7.22M | $8.46B | 6.90% | 69 Neutral | |
| American Water | 3.96% | $7.19M | $25.53B | -4.32% | 65 Neutral |
CWS Technical Analysis
Positive
―
Price Trends
68.40
Positive
68.84
Negative
67.48
Positive
Market Momentum
-0.13
Negative
53.54
Neutral
73.44
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CWS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 68.21, equal to the 50-day MA of 68.40, and equal to the 200-day MA of 67.48, indicating a bullish trend. The MACD of -0.13 indicates Negative momentum. The RSI at 53.54 is Neutral, neither overbought nor oversold. The STOCH value of 73.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CWS.
CWS Peer Comparison
Comparison Results
Performance Comparison
CWS
AdvisorShares Focused Equity ETF
68.60
-2.32
-3.27%
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents